Topical 0.4% Ketorolac and Vitreoretinal Surgery

Phase 3CompletedNCT00576329

Emory University76 enrolled

Overview

To determine whether use of topical 0.4% ketorolac has any effect on pupil size during vitreoretinal surgery.

Other outcomes will be to assess postoperative pain and inflammation and visual acuity.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

DOUBLE

Enrollment

Conditions

Surgery

Interventions

KetorolacDRUG

Topical use before surgery

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Age of 18, routine elective vitrectomy Exclusion Criteria: * history of trauma, uveitis, prior intraocular surgery within 3 months, requirement of mechanical pupil dilation, prior inclusion of other eye

Locations (1)

Emory Eye Clinic

Atlanta, Georgia, United States

Outcomes

Primary Outcomes

Change in pupil size during vitreoretinal surgery

Time frame: Surgery

Secondary Outcomes

Postoperative pain and inflammation

Time frame: 1 day

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.